vs
艾伯维（ABBV）与美国银行（BAC）财务数据对比。点击上方公司名可切换其他公司
美国银行的季度营收约是艾伯维的1.9倍（$31.2B vs $16.6B），美国银行净利率更高（24.1% vs 10.9%，领先13.2%），过去两年艾伯维的营收复合增速更高（16.2% vs 11.3%）
艾伯维是一家总部位于美国伊利诺伊州北芝加哥的制药企业，专注于研发、生产覆盖多种疾病领域的治疗药物，致力于为全球各地患者提供安全有效的临床解决方案，在全球医药行业拥有较高的知名度与影响力。
美国银行是美国知名跨国投资银行及金融服务控股集团，总部位于北卡罗来纳州夏洛特的美国银行企业中心，在曼哈顿设有投行业务及辅助办公总部，1998年由国民银行与原美国银行合并组建，为全球客户提供多元化综合金融服务。
ABBV vs BAC — 直观对比
营收规模更大
BAC
是对方的1.9倍
$16.6B
净利率更高
BAC
高出13.2%
10.9%
两年增速更快
ABBV
近两年复合增速
11.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.6B | $31.2B |
| 净利润 | $1.8B | $7.5B |
| 毛利率 | 72.6% | — |
| 营业利润率 | 27.3% | 39.9% |
| 净利率 | 10.9% | 24.1% |
| 营收同比 | 10.0% | — |
| 净利润同比 | 8354.5% | — |
| 每股收益（稀释后） | $1.02 | $0.96 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABBVBAC
| Q4 25 | $16.6B | $31.2B | ||
| Q3 25 | $15.8B | $28.1B | ||
| Q2 25 | $15.4B | $26.5B | ||
| Q1 25 | $13.3B | $27.4B | ||
| Q4 24 | $15.1B | — | ||
| Q3 24 | $14.5B | $25.3B | ||
| Q2 24 | $14.5B | $25.4B | ||
| Q1 24 | $12.3B | $25.8B |
净利润ABBVBAC
| Q4 25 | $1.8B | $7.5B | ||
| Q3 25 | $186.0M | $8.5B | ||
| Q2 25 | $938.0M | $7.1B | ||
| Q1 25 | $1.3B | $7.4B | ||
| Q4 24 | $-22.0M | — | ||
| Q3 24 | $1.6B | $6.9B | ||
| Q2 24 | $1.4B | $6.9B | ||
| Q1 24 | $1.4B | $6.7B |
毛利率ABBVBAC
| Q4 25 | 72.6% | — | ||
| Q3 25 | 66.4% | — | ||
| Q2 25 | 71.8% | — | ||
| Q1 25 | 70.0% | — | ||
| Q4 24 | 70.9% | — | ||
| Q3 24 | 70.9% | — | ||
| Q2 24 | 70.9% | — | ||
| Q1 24 | 66.7% | — |
营业利润率ABBVBAC
| Q4 25 | 27.3% | 39.9% | ||
| Q3 25 | 12.1% | 33.7% | ||
| Q2 25 | 31.7% | 29.1% | ||
| Q1 25 | 28.0% | 29.7% | ||
| Q4 24 | -9.9% | — | ||
| Q3 24 | 26.5% | 28.9% | ||
| Q2 24 | 27.6% | 29.8% | ||
| Q1 24 | 22.7% | 28.1% |
净利率ABBVBAC
| Q4 25 | 10.9% | 24.1% | ||
| Q3 25 | 1.2% | 30.2% | ||
| Q2 25 | 6.1% | 26.9% | ||
| Q1 25 | 9.6% | 27.0% | ||
| Q4 24 | -0.1% | — | ||
| Q3 24 | 10.8% | 27.2% | ||
| Q2 24 | 9.5% | 27.2% | ||
| Q1 24 | 11.1% | 25.9% |
每股收益（稀释后）ABBVBAC
| Q4 25 | $1.02 | $0.96 | ||
| Q3 25 | $0.10 | $1.06 | ||
| Q2 25 | $0.52 | $0.89 | ||
| Q1 25 | $0.72 | $0.90 | ||
| Q4 24 | $-0.03 | — | ||
| Q3 24 | $0.88 | $0.81 | ||
| Q2 24 | $0.77 | $0.83 | ||
| Q1 24 | $0.77 | $0.76 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.3B | — |
| 总债务越低越好 | $58.9B | $317.8B |
| 股东权益账面价值 | $-3.3B | $303.2B |
| 总资产 | $134.0B | $3411.7B |
| 负债/权益比越低杠杆越低 | — | 1.05× |
8季度趋势，按日历期对齐
现金及短期投资ABBVBAC
| Q4 25 | $5.3B | — | ||
| Q3 25 | $5.7B | — | ||
| Q2 25 | $6.5B | — | ||
| Q1 25 | $5.2B | — | ||
| Q4 24 | $5.6B | — | ||
| Q3 24 | $7.3B | — | ||
| Q2 24 | $13.2B | — | ||
| Q1 24 | $18.1B | — |
总债务ABBVBAC
| Q4 25 | $58.9B | $317.8B | ||
| Q3 25 | $63.0B | $311.5B | ||
| Q2 25 | $63.0B | $313.4B | ||
| Q1 25 | $64.5B | $304.1B | ||
| Q4 24 | $60.3B | — | ||
| Q3 24 | $58.5B | $296.9B | ||
| Q2 24 | $58.0B | $290.5B | ||
| Q1 24 | $63.8B | $296.3B |
股东权益ABBVBAC
| Q4 25 | $-3.3B | $303.2B | ||
| Q3 25 | $-2.6B | $304.2B | ||
| Q2 25 | $-183.0M | $299.6B | ||
| Q1 25 | $1.4B | $295.6B | ||
| Q4 24 | $3.3B | — | ||
| Q3 24 | $6.0B | $296.5B | ||
| Q2 24 | $6.8B | $293.9B | ||
| Q1 24 | $8.0B | $293.6B |
总资产ABBVBAC
| Q4 25 | $134.0B | $3411.7B | ||
| Q3 25 | $133.9B | $3403.7B | ||
| Q2 25 | $137.2B | $3441.1B | ||
| Q1 25 | $136.2B | $3349.4B | ||
| Q4 24 | $135.2B | — | ||
| Q3 24 | $143.4B | $3324.3B | ||
| Q2 24 | $141.9B | $3258.0B | ||
| Q1 24 | $148.9B | $3273.8B |
负债/权益比ABBVBAC
| Q4 25 | — | 1.05× | ||
| Q3 25 | — | 1.02× | ||
| Q2 25 | — | 1.05× | ||
| Q1 25 | 45.44× | 1.03× | ||
| Q4 24 | 18.15× | — | ||
| Q3 24 | 9.70× | 1.00× | ||
| Q2 24 | 8.56× | 0.99× | ||
| Q1 24 | 7.97× | 1.01× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.2B | $-22.9B |
| 自由现金流经营现金流 - 资本支出 | $4.9B | — |
| 自由现金流率自由现金流/营收 | 29.4% | — |
| 资本支出强度资本支出/营收 | 2.0% | — |
| 现金转化率经营现金流/净利润 | 2.87× | -3.05× |
| 过去12个月自由现金流最近4个季度 | $17.8B | — |
8季度趋势，按日历期对齐
经营现金流ABBVBAC
| Q4 25 | $5.2B | $-22.9B | ||
| Q3 25 | $7.0B | $46.9B | ||
| Q2 25 | $5.2B | $-9.1B | ||
| Q1 25 | $1.6B | $-2.2B | ||
| Q4 24 | $7.0B | — | ||
| Q3 24 | $5.4B | — | ||
| Q2 24 | $2.3B | — | ||
| Q1 24 | $4.0B | $-15.5B |
自由现金流ABBVBAC
| Q4 25 | $4.9B | — | ||
| Q3 25 | $6.6B | — | ||
| Q2 25 | $4.9B | — | ||
| Q1 25 | $1.4B | — | ||
| Q4 24 | $6.8B | — | ||
| Q3 24 | $5.2B | — | ||
| Q2 24 | $2.0B | — | ||
| Q1 24 | $3.8B | — |
自由现金流率ABBVBAC
| Q4 25 | 29.4% | — | ||
| Q3 25 | 42.1% | — | ||
| Q2 25 | 31.7% | — | ||
| Q1 25 | 10.5% | — | ||
| Q4 24 | 44.7% | — | ||
| Q3 24 | 35.9% | — | ||
| Q2 24 | 14.0% | — | ||
| Q1 24 | 31.3% | — |
资本支出强度ABBVBAC
| Q4 25 | 2.0% | — | ||
| Q3 25 | 2.4% | — | ||
| Q2 25 | 1.7% | — | ||
| Q1 25 | 1.8% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 1.7% | — | ||
| Q1 24 | 1.6% | — |
现金转化率ABBVBAC
| Q4 25 | 2.87× | -3.05× | ||
| Q3 25 | 37.76× | 5.53× | ||
| Q2 25 | 5.49× | -1.28× | ||
| Q1 25 | 1.27× | -0.30× | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.49× | — | ||
| Q2 24 | 1.66× | — | ||
| Q1 24 | 2.95× | -2.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ABBV
暂无分部数据
BAC
| Other | $7.0B | 22% |
| Global Wealth And Investment Management Segment | $6.6B | 21% |
| Global Banking Segment | $6.2B | 20% |
| Global Markets Segment | $5.3B | 17% |
| Investment And Brokerage Services Asset Management Fees | $4.2B | 13% |
| Investment Banking Income Underwriting Income | $752.0M | 2% |
| Investment Banking Income Financial Advisory Services | $590.0M | 2% |
| Investment Banking Income Syndication Fees | $324.0M | 1% |
| Corporate Securities Trading Loansand Other | $184.0M | 1% |
| Mortgage Trading Loans Mortgage Backed Securities And Asset Backed Securities | $31.0M | 0% |
| Equity Securities | $12.0M | 0% |
| Accrued Expensesand Other Liabilities | $11.0M | 0% |
